Regulation & Policy
Regulation & policy
Make an Inquiry
Make inquiry a secret.
Forgot your ID/PW?
Most Read News
It is ‘good or bad’ to introduce products from multinational pharmas?
No. of Korean drugs approved in U.S. and Europe exceeds double digit
What are strategic considerations for IPR in U.S. pharmaceutical and biotechnology fields?
MFDS designates renal cell carcinoma therapy ‘cabozantinib’ as orphan drug
Celltrion’s Truxima wins all the patent nullification trials in Korea
Online drug shopping mall market fueled with competition
Bill will be prepared for KPA’s ethics commission to make request to revoke license
Listed pharmas’ cash dividends less than the last year
This year’s business key words, “overseas expansion and new drug development” in pharma industry
MFDS announces pharmaceutical products under Drug Utilization Review(DUR)
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: email@example.com
Copyright © Yakup Shinmoon, Inc. All Rights Reserved.